Endoscopic Resection of Rectal Neuroendocrine Tumors: How Deep Should We Go?
Journal of Clinical Medicine · 26.05.2026 · 15 (11) · 4103
DOI: 10.3390/jcm15114103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.05.2026. Verfasst von Kasper Maryńczak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Oncological Surgery, Medical University of Lodz, 90-419 Lodz, Poland. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Background
Rectal neuroendocrine tumors (r-NETs) measuring 20 mm or less are increasingly diagnosed during colorectal cancer screening, but the optimal depth of endoscopic resection remains uncertain. Endoscopic submucosal dissection (ESD) is well established, whereas endoscopic intermuscular dissection (EID) may provide deeper resection for fibrotic or recurrent lesions. We hypothesized that EID would provide reliable deep-margin clearance without compromising safety.
Methods
We retrospectively reviewed 42 consecutive patients treated at a tertiary center between 2018 and 2025. Thirty-two primary lesions underwent ESD and 10 lesions or scars suspicious for deep invasion underwent EID. Primary outcomes were en bloc and R0 resection; secondary outcomes were procedure time, adverse events, and length of stay. Groups were compared with the t, Mann–Whitney U, and chi-square tests.
Results
En bloc resection was achieved in all cases. Histology confirmed R0 resection in all 26 primary lesions. Among 16 excision scars, 14 showed fibrosis only and 2 harbored grade 1 NET recurrence; both recurrent lesions were resected R0 with EID. Lesion size and procedure time were similar between groups. No major adverse events occurred. Self-limited intraprocedural bleeding occurred in five patients, and all patients were discharged within 2 postoperative days.
Conclusions
Both techniques are safe and effective for r-NETs measuring 20 mm or less, and EID may be preferred for fibrotic or recurrent lesions. Large prospective multicentre studies are needed to validate the depth-tailored use of EID in r-NETs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General and Oncological Surgery, Medical University of Lodz, 90-419 Lodz, Poland.
- Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 92-215 Lodz, Poland.
- Department of Surgery, Faculty of Health Sciences, Jagiellonian University Medical College, 31-501 Krakow, Poland.
ORCID-Profile: Kasper Maryńczak, Przemysław Kasprzyk, Karol Pierzchała, Aleksandra Osielczak, Zofia Orzeszko, Łukasz Dziki, Michał Spychalski
Förderung
- Medical University of Lodz
Zitieren
APA
Maryńczak, K., Kasprzyk, P., Pierzchała, K., Osielczak, A., Orzeszko, Z., Dziki, Ł., & Spychalski, M. (2026). Endoscopic Resection of Rectal Neuroendocrine Tumors: How Deep Should We Go?. Journal of Clinical Medicine, 15(11), 4103. https://doi.org/10.3390/jcm15114103
Vancouver
Maryńczak K, Kasprzyk P, Pierzchała K, Osielczak A, Orzeszko Z, Dziki Ł, et al. Endoscopic Resection of Rectal Neuroendocrine Tumors: How Deep Should We Go?. Journal of Clinical Medicine. 2026;15(11):4103. doi:10.3390/jcm15114103
BibTeX
@article{Maryczak2026,
author = {Maryńczak, Kasper and Kasprzyk, Przemysław and Pierzchała, Karol and Osielczak, Aleksandra and Orzeszko, Zofia and Dziki, Łukasz and Spychalski, Michał},
title = {Endoscopic Resection of Rectal Neuroendocrine Tumors: How Deep Should We Go?},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4103},
doi = {10.3390/jcm15114103}
}
EUVIMED